EyePoint Pharmaceuticals Announces Pricing of Upsized Public Offering
WATERTOWN, Mass., Oct. 29, 2024 ( GLOBE NEWSWIRE ) -- EyePoint Pharmaceuticals, Inc. ( NASDAQ: EYPT ) , a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced the pricing of an underwritten ...
| Ticker |
Sentiment |
Impact |
|
BR
|
Neutral
|
6 %
|
|
EYPT
|
Neutral
|
14 %
|
|
C
|
Neutral
|
6 %
|
